title: Efficacy of oral administration of lactic acid bacteria isolated from cocoa in a fermented milk preparation: reduction of colitis in an experimental rat model.
abstract: We investigated the probiotic potential of lactic acid bacteria (LAB) obtained from cocoa fermentation using an experimental rat model of colitis. Cocoa beans were collected from fermentation boxes every 12 h for 5 days to isolate the microorganisms. Strains were isolated by serial dilution and plating on MRS agar. Gram-positive and catalase-negative rods were subjected to DNA extraction, polymerase chain reaction, and sequencing. Ten strains were randomly pooled and used to prepare a fermented milk drink that was used to treat the experimental colitis. A parallel group was treated with a single strain drink. Serum concentrations of cytokines and IgA, total and differential counts of blood leukocytes, and histological appearance were compared with the untreated control colitis group. Eighty strains of LAB were identified as Lactobacillus fermentum (68) and Lactobacillus plantarum (12). The multi-strain LAB pool significantly reduced the total number of leukocytes. There was a significant reduction in the percentage of neutrophils and monocytes compared with the control colitis group. IFN-γ concentration was downregulated in animals treated with the LAB pool. IL-10 and IgA increased significantly in the group treated with the strains. Histological analysis showed that the LAB pool reduced the inflammatory infiltrate and restored tissue architecture. The group treated with the single strain LAB drink (L. fermentum) showed no signs of inflammation remission. The results confirm the probiotic action of cocoa-derived LAB in the treatment of experimental colitis. Studies using isogenic models and humans will clarify the mechanisms of immune response modulation in inflammatory bowel disease.
authors.affiliation: Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Salobrinho, Ilhéus, BA, Brasil.
authors.forename: T F
authors.initials: TF
authors.lastname: Dos Santos
authors.affiliation: Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Salobrinho, Ilhéus, BA, Brasil.
authors.forename: T A
authors.initials: TA
authors.lastname: Melo
authors.affiliation: Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Salobrinho, Ilhéus, BA, Brasil.
authors.forename: D S
authors.initials: DS
authors.lastname: Santos
authors.affiliation: Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Salobrinho, Ilhéus, BA, Brasil.
authors.forename: R P
authors.initials: RP
authors.lastname: Rezende
authors.affiliation: Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Salobrinho, Ilhéus, BA, Brasil.
authors.forename: J C T
authors.initials: JC
authors.lastname: Dias
authors.affiliation: Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Salobrinho, Ilhéus, BA, Brasil romanocc@uol.com.br.
authors.forename: C C
authors.initials: CC
authors.lastname: Romano
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002099:Cacao / Q000382:microbiology*; D003092:Colitis / Q000097:blood / Q000276:immunology / Q000628:therapy*; D003106:Colon / Q000276:immunology / Q000473:pathology; D043302:Cultured Milk Products / Q000382:microbiology*; D016207:Cytokines / Q000097:blood; D005285:Fermentation; D007070:Immunoglobulin A / Q000097:blood; D052197:Limosilactobacillus fermentum / Q000302:isolation & purification*; D048191:Lactiplantibacillus plantarum / Q000302:isolation & purification*; D018655:Lymphocyte Count; D008297:Male; D019936:Probiotics / Q000008:administration & dosage*; D017208:Rats, Wistar
chemical_list: D016207:Cytokines; D007070:Immunoglobulin A